Cargando…

Alpha-Gal Bound Aptamer and Vancomycin Synergistically Reduce Staphylococcus aureus Infection In Vivo

Methicillin-resistant Staphylococcus aureus (MRSA) is a pervasive and persistent threat that requires the development of novel therapies or adjuvants for existing ones. Aptamers, small single-stranded oligonucleotides that form 3D structures and can bind to target molecules, provide one possible the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doherty, Matthew K., Shaw, Claire, Woods, Leslie, Weimer, Bart C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383818/ https://www.ncbi.nlm.nih.gov/pubmed/37512948 http://dx.doi.org/10.3390/microorganisms11071776

Ejemplares similares

Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
por: SRİSRATTAKARN, Arpasiri, et al.
Publicado: (2021)

Vancomycin Resistance in Staphylococcus aureus 
por: McGuinness, Will A., et al.
Publicado: (2017)

Reduced Susceptibility to Vancomycin in Staphylococcus aureus
por: Mimica, Marcelo J.
Publicado: (2011)

Evaluating vancomycin susceptibility in Staphylococcus aureus
por: Mimica, Marcelo J, et al.
Publicado: (2016)

Determination of Vancomycin-resistant Staphylococcus aureus
por: Ghasabi, Farzane, et al.
Publicado: (2017)

Vancomycin Resistance in Enterococcus and Staphylococcus aureus
por: Li, Gen, et al.
Publicado: (2022)

Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)

Synergistic Effect between Cryptotanshinone and Antibiotics against Clinic Methicillin and Vancomycin-Resistant Staphylococcus aureus
por: Cha, Jeong-Dan, et al.
Publicado: (2014)

Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus
por: Hu, Qiwen, et al.
Publicado: (2016)

Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
por: Ramaraj, Thiruvarangan, et al.
Publicado: (2014)

Alpha-amyrin as an anti-biofilm agent against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus
por: Chung, Pooi Yin, et al.
Publicado: (2023)

Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
por: Peng, Huagang, et al.
Publicado: (2018)

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus
por: Katayama, Yuki, et al.
Publicado: (2016)

Efficacy of Combined Vancomycin and Fosfomycin against Methicillin-Resistant Staphylococcus aureus in Biofilms In Vivo
por: Shi, Jian, et al.
Publicado: (2014)

Optimization of Vancomycin Aptamer Sequence Length Increases the Sensitivity of Electrochemical, Aptamer-Based Sensors In Vivo
por: Shaver, Alexander, et al.
Publicado: (2022)

Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
por: Liang, Jin, et al.
Publicado: (2023)

Tick salivary gland extract induces alpha‐gal syndrome in alpha‐gal deficient mice
por: Choudhary, Shailesh K., et al.
Publicado: (2021)

Aptamer-Targeted Drug Delivery for Staphylococcus aureus Biofilm
por: Ommen, Pernille, et al.
Publicado: (2022)

Vancomycin-Resistant Staphylococcus aureus, Michigan, USA, 2007
por: Finks, Jennie, et al.
Publicado: (2009)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Genomic Analysis of the Emergence of Vancomycin-Resistant Staphylococcus aureus
por: Kobayashi, Scott D., et al.
Publicado: (2012)

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
por: Tenover, F C, et al.
Publicado: (2001)

Emergence of Vancomycin-Intermediate Staphylococcus aureus and S. sciuri, Greece
por: Tsakris, Athanassios, et al.
Publicado: (2002)

Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus
por: Sirichoat, Auttawit, et al.
Publicado: (2016)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings
por: SPAGNOLO, A.M., et al.
Publicado: (2014)

Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus
por: Rishishwar, Lavanya, et al.
Publicado: (2016)

Clinical implications of vancomycin susceptibility testing in Staphylococcus aureus
por: Mimica, Marcelo J.
Publicado: (2013)

Antimicrobial pharmacodynamics of vancomycin and disulfiram (Antabuse®) in Staphylococcus aureus
por: Chavva, Hasitha, et al.
Publicado: (2023)

Vancomycin Activates σ(B) in Vancomycin-Resistant Staphylococcus aureus Resulting in the Enhancement of Cytotoxicity
por: Chen, Hong-Yi, et al.
Publicado: (2011)

Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
por: Lin, Lee-Chung, et al.
Publicado: (2018)

Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis
por: Mirzaei, Rasoul, et al.
Publicado: (2022)

Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization
por: Furuno, Jon P., et al.
Publicado: (2005)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
por: Howe, Robin A., et al.
Publicado: (2004)

Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
por: Lin, Chien-Yu, et al.
Publicado: (2018)

Phenotypic Plasticity of Staphylococcus aureus in Liquid Medium Containing Vancomycin
por: Rong, Mengdi, et al.
Publicado: (2019)

Molecular epidemiology of heteroresistant vancomycin-intermediate Staphylococcus aureus in Brazil
por: Silveira, Alessandro Conrado de Oliveira, et al.
Publicado: (2015)

Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia
por: Ejaz, Mohammad, et al.
Publicado: (2023)

Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening
por: Cázares-Domínguez, Vicenta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pdfoqsqdsmmumv896f45urjpid